Showing results (551-560 of 1,087) with videos related to
Sort By:
Pageof 109
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 25, 2025
Advances in coronary imaging of atherosclerotic plaquesHector M Garcia-Garcia, Jorge Sanz-Sanchez, Natalia Pinilla-Echeverri, et al.Coronary Artery Disease|January 19, 2018
Complete revascularization for patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease: a meta-analysis of randomized trialsGani Bajraktari, Haki Jashari, Pranvera Ibrahimi, et al.Journal of Thoracic Disease|March 14, 2019
Erratum to spontaneous coronary artery dissection: from expert consensus statements to evidence-based medicineFernando Alfonso, Marcos García-Guimaraes, Teresa Bastante, et al.Journal of Thoracic Disease|September 4, 2018
Spontaneous coronary artery dissection: from expert consensus statements to evidence-based medicineFernando Alfonso, Marcos García-Guimaraes, Teresa Bastante, et al.Journal of Cataract and Refractive Surgery|December 24, 2014
Collagen copolymer posterior chamber phakic intraocular lens supported by the ciliary sulcus to treat myopia: one-year follow-upCarlos Lisa, José Fernando Alfonso, Belén Alfonso-Bartolozzi, et al.Cardiology Journal|December 16, 2016
Mother-and-child catheter-facilitated optical coherence tomography: A novel approach to improve intracoronary imagingMarcos Garcia-Guimaraes, Javier Cuesta, Fernando Rivero, et al.JAMA|November 18, 2011
Dosing clopidogrel based on CYP2C19 genotype and the effect on platelet reactivity in patients with stable cardiovascular diseaseJessica L Mega, Willibald Hochholzer, Andrew L Frelinger, et al.Journal of the American College of Cardiology|June 11, 2013
Prasugrel 5 mg in the very elderly attenuates platelet inhibition but maintains noninferiority to prasugrel 10 mg in nonelderly patients: the GENERATIONS trial, a pharmacodynamic and pharmacokinetic study in stable coronary artery disease patientsDavid Erlinge, Paul A Gurbel, Stefan James, et al.Journal of the American College of Cardiology|June 25, 2011
Impact of insulin receptor substrate-1 genotypes on platelet reactivity and cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery diseaseDominick J Angiolillo, Esther Bernardo, Martina Zanoni, et al.TH Open : Companion Journal to Thrombosis and Haemostasis|December 30, 2020
Antiplatelet Therapy with Cangrelor in Patients Undergoing Surgery after Coronary Stent Implantation: A Real-World Bridging Protocol ExperienceRoberta Rossini, Giulia Masiero, Claudia Fruttero, et al.Pageof 109